InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock

... TEL AVIV Israel March 7 2013 /PRNewswire/...InspireMD Inc. (OTC: NSPR) (the Company or InspireMD ) filed an am...In addition InspireMD intends to grant the underwriters a 30-day opti...The Company intends to use the proceeds from the offering to support t...

InspireMD, Inc. (OTC: NSPR) (the "Company" or "InspireMD") filed an amended registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the resumption of a proposed underwritten public offering. Under the amended registration statement, the Company is offering $30 million worth of its shares of common stock.

In addition, InspireMD intends to grant the underwriters a 30-day option to purchase up to an aggregate of 15 percent additional shares of common stock to cover over-allotments, if any.

The Company intends to use the proceeds from the offering to support the worldwide commercialization of the MGuard™ Coronary in acute myocardial infarction, pursue FDA approval in the U.S., to redeem its convertible debentures, and for general corporate purposes.

As part of the offering, the Company has applied to list its shares of common stock on the NYSE MKT.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

Cowen and Company, LLC is sole book runner and JMP Securities is acting as co-lead manager. This offering shall be made only by means of a prospectus. Once available, a prospectus relating to these securities may be obtained from Cowen and Company, LLC (c/o Broadridge Financial Services) at 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, or by calling +1(631)274-2806.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About InspireMD, Inc.

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is quoted on the OTCBB under the ticker symbol NSPR.

Forward-looking Statements

This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multi-national companies, (v) product liability claims, (vi) our limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) our reliance on single suppliers for certain product components, (xi) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Transition Report on From 10-K/T and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

(Date:8/15/2017)... Aug. 15, 2017 Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...

(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...

(Date:8/17/2017)... , ... August 17, 2017 , ... Advice Media, the industry leader in digital marketing ... in North America and has been included in the Inc. 5000 for the second time ... to be included in the Inc. 5000 rankings for the second year in a row. ...

(Date:8/16/2017)... ... August 16, 2017 , ... Summer days spent with family are priceless. ... put together suggestions for enjoying the season of sunshine. Add trying something new to ... family can join in on the fun. , Try Something New ...

(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater ... Classroom and will win a visit by a Houston Texans player, two tickets to ... least five years old can visit texanschecking.com/stars to nominate their favorite teacher with an ...

(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... In a ... its appearance with diet and exercise. In fact, cellulite can't always be eliminated by ... and more effective treatment available to select physicians nationwide. Dr. Kenneth Rothaus has recently ...